Search IconSearch
March 20, 2020/COVID-19

A Pulmonary Pathologist’s Perspective on COVID-19

ARDS, diffuse alveolar damage and hypoxia

In this video recorded in March 2020, Sanjay Mukhopadhyay, MD, Director of Pulmonary Pathology in the Department of Anatomic Pathology, presents an overview of COVID-19, starting with the global numbers and ending with what he and other pathologists are seeing under their microscopes. He explains the histology of acute respiratory distress syndrome (ARDS) as it relates to COVID-19 and other respiratory illnesses. He also highlights the diffuse alveolar damage that pathologists see in patients who are infected with the virus by comparing a normal lung and a lung impacted by diffuse alveolar damage. Finally, Dr. Mukhopadhyay offers a patient-friendly explanation of alveolar function and hypoxia from the cellular level to symptom presentation.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“I decided to do this talk at the suggestion of a doctor… who made an impassioned plea on YouTube to people to take the pandemic seriously,” says Dr. Mukhopadhyay. He makes his own impassioned plea at the end of the video: “My take-home message to you is not to take COVID-19 lightly. Please don’t dismiss this as just another… viral infection that will pass. The most severe forms of COVID-19 can cause ARDS. As I’ve shown you, this is a very highly dangerous and potentially fatal form of lung damage. Please take all the precautions that the CDC is outlining.”

While Dr. Mukhopadhyay created the video in the very early days of the pandemic, his explanations of the relationship between COVID-19, ARDS, severe lung damage and death remains pertinent for at-risk patients and may be interesting to clinicians in other specialties. Dr. Mukhopadhyay draws upon the experience of Cleveland Clinic’s pulmonary pathology service, which handles 5,000 cases per year and supports a large group of pulmonologists and thoracic surgeons as well as one of the busiest lung transplant services in the world. In 2020, Dr. Mukhopadhyay was featured in a New York Times video on COVID-19 and ARDS that has been viewed more than 2 million times.

A Pulmonary Pathologist's Perspective on COVID-19

Related Articles

Stellate Ganglion Block
May 17, 2023/COVID-19
Nerve Block Shows Promise for Long COVID-Related Olfactory or Gustatory Dysfunction

Patients report improved sense of smell and taste

Covid image
April 26, 2023/COVID-19
What Long COVID Means for Rheumatologists (Video)

Clinicians who are accustomed to uncertainty can do well by patients

Covid related skin effects
April 4, 2023/COVID-19
Cutaneous Manifestations of COVID-19 in Special Populations

Unique skin changes can occur after infection or vaccine

February 10, 2023/COVID-19
Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

January 13, 2023/COVID-19
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era

As the pandemic evolves, rheumatologists must continue to be mindful of most vulnerable patients

covid-19 virus
January 12, 2023/COVID-19
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients

Early results suggest positive outcomes from COVID-19 PrEP treatment

Eosinophilic Fasciitis
November 29, 2022/COVID-19
New Onset Eosinophilic Fasciitis after COVID-19 Infection

Could the virus have caused the condition or triggered previously undiagnosed disease?

COVID-19 and rash
June 16, 2022/COVID-19
Common Skin Signs of COVID-19 in Adults: An Update

Five categories of cutaneous abnormalities are associated with COVID-19